KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme (CME) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for Cme (CME) over the last 17 years, with Q3 2025 value amounting to $24.0 million.

  • Cme's Share-based Compensation rose 1822.66% to $24.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $93.0 million, marking a year-over-year increase of 726.64%. This contributed to the annual value of $89.5 million for FY2024, which is 796.14% up from last year.
  • Cme's Share-based Compensation amounted to $24.0 million in Q3 2025, which was up 1822.66% from $20.7 million recorded in Q2 2025.
  • Cme's 5-year Share-based Compensation high stood at $27.1 million for Q4 2024, and its period low was $15.6 million during Q3 2021.
  • Over the past 5 years, Cme's median Share-based Compensation value was $20.2 million (recorded in 2023), while the average stood at $20.9 million.
  • Per our database at Business Quant, Cme's Share-based Compensation tumbled by 3445.38% in 2021 and then soared by 3709.68% in 2022.
  • Cme's Share-based Compensation (Quarter) stood at $18.6 million in 2021, then skyrocketed by 37.1% to $25.5 million in 2022, then decreased by 4.71% to $24.3 million in 2023, then grew by 11.52% to $27.1 million in 2024, then fell by 11.44% to $24.0 million in 2025.
  • Its Share-based Compensation was $24.0 million in Q3 2025, compared to $20.7 million in Q2 2025 and $21.2 million in Q1 2025.